XM does not provide services to residents of the United States of America.

U.S. STOCKS Atlassian, Comerica, Tesla



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-U.S. STOCKS ON THE MOVE-Atlassian, Comerica, Tesla</title></head><body>

Eikon search string for individual stock moves: STXBZ

The Day Ahead newsletter: https://refini.tv/3LI4BU7

The Morning News Call newsletter: https://refini.tv/3dKUyB8

U.S. stock index futures fell on Tuesday as megacap stocks retreated after a strong session, with additional caution creeping in ahead of jobs opening data and comments from Federal Reserve Chairman Jerome Powell later in the day. .N


At 7:41 ET, Dow e-minis 1YMc1 were down 0.38% at 39,362. S&P 500 e-minis ESc1 were down 0.46% at 5,508.5, while Nasdaq 100 e-minis NQc1 were down 0.60% at 19,932.

The top three NYSE percentage gainers premarket .PRPG.NQ:
** Velo3D <VLD>, up 8.5%
** American Well <AMWL.K>, up 7.4%
** Lanvin Group <LANV.K>, up 7.0%

The top three NYSE percentage losers premarket .PRPL.NQ:
** Hudson Pacific Properties <HPP>, down 10.9%
** CS Disco <LAW>, down 7.9%
** BIT Mining <BTCM.K>, down 6.4%

The top two Nasdaq percentage gainers premarket .PRPG.O:
** Chicken Soup for the Soul Entertainment <CSSEP.O>, up 138.9%
** Versus Systems <VS.O>, up 67.3%

The top three Nasdaq percentage losers premarket .PRPL.O:
** Conn's Inc <CONN.O>, down 44.3%
** Blue World Acquisition <TOYO.O>, down 41%
** Celularity <CELU.O>, down 19.7%


** Paramount Global PARA.O: up 3.1% premarket
BUZZ - Climbs on after Barry Diller's IAC's interest to take control nL4N3IU0JZ


** CrowdStrike CRWD.O: down 2.4% premarket
BUZZ - Skids after Piper Sandler cuts rating nL4N3IU0M4


** Atlassian TEAM.O: up 2.2% premarket
BUZZ - Up after Piper Sandler raises to "overweight" nL4N3IU0NC


** Tesla TSLA.O: down 1.5% premarket
BUZZ - Falls ahead of Q2 deliveries report nL4N3IU0LZ


** Comerica CMA.N: up 1.4% premarket
BUZZ - Inches up after Raymond James upgrade nL4N3IU0S5


** Webtoon Entertainment WBTN.O: down 4.5% premarket
BUZZ - Sags below IPO price after first-day jump nL1N3IU0BF


** Incyte INCY.O: down 3.1% premarket
BUZZ - Drops after BMO downgrades to 'underperform' nL4N3IU0SY


(Compiled by Rajarshi Roy and Arasu Kannagi Basil in Bengaluru)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.